A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Arintra Raises $21M to Expand Beyond Autonomous Medical Coding –Healthradar12. August 2025 What You Should Know: – Arintra, the leading GenAI-native autonomous medical coding platform for healthcare providers, has raised $21 million in…
